Megan Manuel
Impact in
- Hematology top 10%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
-
- Cancer, Hypoxia, and Metabolism
Papers in
- Hematology 18
- Acute Myeloid Leukemia Research 17
-
- Histone Deacetylase Inhibitors Research 9
- Protein Degradation and Inhibitors 3
- Co-authors
- Bayard L. Powell (25 shared papers)Susan Lyerly (25 shared papers)Leslie R. Ellis (23 shared papers)Timothy S. Pardee (24 shared papers)Sarah Dralle (23 shared papers)Scott Isom (17 shared papers)Lance D. Miller (4 shared papers)David D. Hurd (9 shared papers)
- Journals
- Blood (12 papers)Journal of Clinical Oncology (4 papers)Annals of Hematology (2 papers)Clinical Cancer Research (2 papers)Leukemia Research (2 papers)
- Partner nations
- United StatesIsraelUnited Kingdom
In The Last Decade
Megan Manuel
25 papers receiving 320 citations
Peers
Comparison fields: 5 of 53
- Hematology 132
- Cancer Research 145
- Biochemistry 22
- Molecular Biology 205
- Oncology 42
Countries citing papers authored by Megan Manuel
This map shows the geographic impact of Megan Manuel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Megan Manuel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Megan Manuel more than expected).
Fields of papers citing papers by Megan Manuel
This network shows the impact of papers produced by Megan Manuel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Megan Manuel. The network helps show where Megan Manuel may publish in the future.
Co-authors
The 25 scholars most cited alongside Megan Manuel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 91 | |
| 2 | 2018 | 80 | |
| 3 | 2013 | 46 | |
| 4 | 2022 | 28 | |
| 5 | 2015 | 19 | |
| 6 | 2022 | 9 | |
| 7 | 2020 | 9 | |
| 8 | 2021 | 5 | |
| 9 | 2020 | 4 | |
| 10 | 2016 | 4 | |
| 11 | 2018 | 4 | |
| 12 | 2008 | 3 | |
| 13 | 2021 | 3 | |
| 14 | 2015 | 3 | |
| 15 | 2019 | 3 | |
| 16 | 2021 | 2 | |
| 17 | 2012 | 2 | |
| 18 | 2017 | 1 | |
| 19 | 2017 | 1 | |
| 20 | 2014 | 1 |
About Megan Manuel
Megan Manuel is a scholar working on Hematology, Molecular Biology, Public Health, Environmental and Occupational Health, Cancer Research and Pulmonary and Respiratory Medicine, having authored 27 papers that have together received 323 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (17 papers), Histone Deacetylase Inhibitors Research (9 papers), Cancer, Hypoxia, and Metabolism (7 papers), Acute Lymphoblastic Leukemia research (6 papers), Protein Degradation and Inhibitors (3 papers), Lung Cancer Treatments and Mutations (3 papers), Metabolism and Genetic Disorders (2 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers). The work is most often cited by research in Hematology (132 citations), Cancer Research (145 citations), Biochemistry (22 citations), Molecular Biology (205 citations) and Oncology (42 citations). Megan Manuel has collaborated with scholars based in United States, Israel and United Kingdom. Frequent co-authors include Bayard L. Powell, Susan Lyerly, Leslie R. Ellis, Timothy S. Pardee, Sarah Dralle, Scott Isom, Lance D. Miller, David D. Hurd, Dmitriy Berenzon and Dianna S. Howard. Their work appears in journals such as Blood, Journal of Clinical Oncology, Annals of Hematology, Clinical Cancer Research and Leukemia Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.